LONDON - Pfizer Inc. made a strategic advance into vaccines, acquiring DNA vaccines specialist PowderMed Ltd. The value of the deal, which includes a needle-free delivery system and a portfolio of products, was not disclosed. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentPARIS - Faust Pharmaceuticals, which is developing therapies for nervous system diseases, completed an €8.2 million insider bridge financing, which is intended to be the first tranche of a €25 million C round funding. Read More
